Induction of angiogenesis in the β-amyloid peptide-injected rat hippocampus

NeuroReport

Volumn 16, Issue 2, 2005, Pages 129-132

  Zand, Ladan ^a   Ryu, Jae K ^a   McLarnon, James G ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease Amyloid peptide; Angiogenesis; Astrocytes; Inflammation; Microglia; VEGF

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; LAMININ; VASCULOTROPIN;

ALZHEIMER DISEASE; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; CONTROLLED STUDY; HIPPOCAMPUS; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INFLAMMATION; MALE; MICROGLIA; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

AMYLOID BETA-PROTEIN; ANIMALS; HIPPOCAMPUS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 13844294040     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200502080-00011     Document Type: Article

References (20)

1. Selkoe DJ. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev 2001; 81:741-766.
2. Zlokovic BV. Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets. Adv Drug Deliv Rev 2002; 54:1553-1559.
3. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004; 3:184-190.
4. de la Torre JC. Alzheimer disease as a vascular disorder: nosological evidence. Stroke 2002; 33:1152-1162.
5. Yamada M. Cerebral amyloid angiopathy: an overview. Neuropathology 2000; 20:8-22.
6. Perlmutter LS, Chui HC, Saperia D and Athanikar J. Microangiopathy and the colocalization of heparan sulfate proteoglycan with amyloid in senile plaques of Alzheimer's disease. Brain Res 1990; 508:13-19.
7. Vagnucci AH Jr and Li WW. Alzheimer's disease and angiogenesis. Lancet 2003; 361:605-608.
8. Carmeliet P and Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407:249-257.
9. Pogue AI and Lukiw WJ. Angiogenic signaling in Alzheimer's disease. Neuroreport 2004; 15:1507-1510.
10. Jantaratnotai N, Ryu JK, Kim SU and McLarnon JG. Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. Neuroreport 2003; 14:1429-1433.
11. Ryu JK, Franciosi S, Sattayaprasert P, Kim SU and McLarnon JG. Minocycline inhibits neuronal death and glial activation induced by beta-amyloid peptide in rat hippocampus. Glia 2004; 48:85-90.
12. Ryu JK, Kim SU and McLarnon JG. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease. Exp Neurol 2004; 187:150-159.
13. Casella GT, Marcillo A, Bunge MB and Wood PM. New vascular tissue rapidly replaces neural parenchyma and vessels destroyed by a contusion injury to the rat spinal cord. Exp Neurol 2002; 173:63-76.
14. Chen ZL and Strickland S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 1997; 91:917-925.
15. Krum JM and Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: roles for VEGF in brain repair. Exp Neurol 2003; 181:241-257.
16. Weldon DT, Rogers SD, Ghilardi JR, Finke MP, Cleary JP, O'Hare E et al. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo. J Neurosci 1998; 18:2161-2173.
17. Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC and Lust WD. Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 1998; 62:101-105.
18. Yoshida S, Ono M, Shono T, Izumi H, Ishibashi T, Suzuki H et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis. Mol Cell Biol 1997; 17:4015-4023.
19. Jackson JR, Seed MP, Kircher CH, Willoughby DA and Winkler JD. The codependence of angiogenesis and chronic inflammation. FASEB J 1997; 11:457-465.
20. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A and Kumar P. Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 2002; 23:237-243.